SCHEMBL4189252

SCHEMBL4189252

O=C(Nc1ccc(Cl)cn1)c1cc(Cl)[nH]n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.58
L3MBTL1 Q9Y468 1/20 0.57
BRD4 O60885 1/20 0.55
PTK2 Q05397 1/20 0.54
RAB9A P51151 8/20 0.54
SMN1; SMN2 Q16637 6/20 0.54
TSHR P16473 4/20 0.54
TP53 P04637 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
NPC1 O15118 6/20 0.52
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 1/20 0.52
PKM P14618 1/20 0.52
POLB P06746 1/20 0.52
MEN1 O00255 2/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
CGAS Q8N884 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187822 0.86 GRM5 (0.51) ALOX15BRD4RAB9ASMN1; SMN2TSHR
SCHEMBL4182877 0.82 PTGS1 (0.55) ALOX15RAB9ANPC1
SCHEMBL4256925 0.81 NPC1 (0.51) ALOX15RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL4178453 0.81 GAA (0.56) L3MBTL1RAB9ASMN1; SMN2NPC1KMT2A
SCHEMBL4192471 0.78 L3MBTL1 (0.58) ALOX15L3MBTL1BRD4PTK2RAB9A
SCHEMBL4253110 0.75 ALOX15 (0.68) ALOX15RAB9ANPC1KMT2AALDH1A1
SCHEMBL4675605 0.74 RAB9A (0.63) ALOX15L3MBTL1BRD4PTK2RAB9A
SCHEMBL24654650 0.73 L3MBTL1 (0.78) ALOX15L3MBTL1BRD4PTK2RAB9A
SCHEMBL29837506 0.73 L3MBTL1 (0.66) ALOX15L3MBTL1BRD4PTK2RAB9A
SCHEMBL28764679 0.73 L3MBTL1 (0.66) ALOX15L3MBTL1BRD4PTK2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090143440-A1 Pyrazoles Useful in the Treatment of Inflammation BIOLIPOX AB (SE) 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090143440-A1 Pyrazoles Useful in the Treatment of Inflammation ALOX15, ALOX12, ALOX15B ALOX15 1/4885L3MBTL1 2716/4885BRD4 2142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.